LMNX (Common Stock)
Data as of 06/18/18 11:03 a.m. ET
Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay
AUSTIN, Texas, June 13, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced the company recently began clinical studies for the Gastrointestinal (GI) Assay on t...
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences
AUSTIN, Texas, May 18, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer of Luminex will participate i...
Events & Presentations
06/05/18 8:00 a.m. ET
Luminex Corp at Jefferies Healthcare Conference
05/21/18 8:00 a.m. ET
Luminex Corp at UBS Global Healthcare Conference
Latest Investor Presentation
Data provided by Nasdaq. Minimum 15 minutes delayed.